rs200471370
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_001267550.2(TTN):āc.72182T>Cā(p.Met24061Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000292 in 1,613,094 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M24061V) has been classified as Likely benign.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.72182T>C | p.Met24061Thr | missense_variant | 326/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.72182T>C | p.Met24061Thr | missense_variant | 326/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 151940Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000137 AC: 34AN: 248154Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134716
GnomAD4 exome AF: 0.000309 AC: 451AN: 1461154Hom.: 2 Cov.: 38 AF XY: 0.000299 AC XY: 217AN XY: 726876
GnomAD4 genome AF: 0.000132 AC: 20AN: 151940Hom.: 0 Cov.: 33 AF XY: 0.0000943 AC XY: 7AN XY: 74200
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 23, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 15, 2021 | This variant is associated with the following publications: (PMID: 27193218, 24503780) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 04, 2014 | - - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 04, 2012 | Variant classified as Uncertain Significance - Favor Benign. The Met21493Thr var iant (TTN) has not been previously reported in the literature, but has been dete cted in 1 Caucasian individual with DCM tested by our laboratory and did not seg regate with disease in 1 affected relative. This variant has been identified in 5/6610 European American chromosomes from a broad, though clinically unspecified population (NHLBI Exome Sequencing Project; http://evs.gs.washington.edu/EVS). Methionine (Met) at position 21493 is conserved in mammals, but not in more dist antly related species, suggesting that a change may be tolerated. Computational predictions are mixed regarding the possible impact to the protein (AlignGVGD = benign, SIFT = pathogenic), though the accuracy of these tools is unknown. Altho ugh this data suggests that the Met21493Thr variant may be benign, additional in formation is needed to fully assess its clinical significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 11, 2024 | Variant summary: TTN c.64478T>C (p.Met21493Thr), also reported as NM_001267550:c.72182T>C (p.Met24061Thr), results in a non-conservative amino acid change located in the A-band region of the encoded protein sequence. Two of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00029 in 1613094 control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in TTN causing recessive disease, allowing no conclusion about variant significance. c.64478T>C has been reported in the literature in individuals affected with dilated cardiomyopathy with atrial fibrillation (example, Pugh_2014). These report(s) do not provide unequivocal conclusions about association of the variant with TTN-related conditions. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 24503780). ClinVar contains an entry for this variant (Variation ID: 47313). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 11, 2017 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 21, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at